UNIVERSITY OF ALABAMA AT BIRMINGHAM

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1969-01-01

Employees: 2K

Market Cap: -

Website: http://www.uab.edu

Clinical Trials

Early DHA/ARA Supplementation in Growth-restricted Very Preterm Infants: A Randomized Clinical Trial

Not Applicable

Recruiting

Conditions: Premature
Infant Malnutrition
Light-For-Dates With Signs of Fetal Malnutrition
Nutrition Disorder, Infant

Interventions: Dietary Supplement: DHA

First Posted Date: 2024-01-16

Last Posted Date: 2024-05-28

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 152

Registration Number: NCT06207071

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

The Fit with Us Study

Not Applicable

Recruiting

Conditions: Mobility Limitations
Disability Physical
Telehealth
Health Coaching
Physical Activity
Behavior, Health
EHealth
Health Literacy
Self Efficacy
Fatigue

Interventions: Behavioral: asynchronous content only
Behavioral: Asynchronous content and health coaching and no live training
Behavioral: Asynchronous content and health coaching and group training
Behavioral: asynchronous content only and 1 on 1 live training
Behavioral: asynchronous content and health coaching and 1 on 1 training
Behavioral: asynchronous content and group training

First Posted Date: 2024-01-16

Last Posted Date: 2024-10-16

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 257

Registration Number: NCT06207084

Locations: 🇺🇸
Wellness, Health and Research Facility, Birmingham, Alabama, United States

Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1)

Phase 1

Not yet recruiting

Conditions: Anaplastic Astrocytoma of Brain
Glioblastoma Multiforme of Brain
Gliosarcoma of Brain
Recurrent Malignant Glioma

Interventions: Drug: C134 Re-Administration

First Posted Date: 2024-01-05

Last Posted Date: 2024-01-19

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 12

Registration Number: NCT06193174

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1

Phase 2

Not yet recruiting

Conditions: Neurofibromatosis 1
Plexiform Neurofibroma

Interventions: Drug: Selumetinib

First Posted Date: 2024-01-03

Last Posted Date: 2024-10-11

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 200

Registration Number: NCT06188741

A Stakeholder-enhanced Intervention to Improve the Decisional Partnership of Chronic Kidney Disease Dyads (IMPART)

Not Applicable

Recruiting

Conditions: Family Caregiving
Decision Making, Shared
Chronic Kidney Disease

Interventions: Behavioral: ImPart - Improving Chronic Kidney Disease Decisional Partnerships

First Posted Date: 2023-12-15

Last Posted Date: 2024-08-21

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 128

Registration Number: NCT06173323

Locations: 🇺🇸
Shena Gazaway, Birmingham, Alabama, United States

DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer

Not Applicable

Not yet recruiting

Conditions: Borderline-resectable Pancreatic Cancer

Interventions: Device: Point-of-care Portable Perfusion Phantom (P4)

First Posted Date: 2023-12-15

Last Posted Date: 2024-07-03

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 50

Registration Number: NCT06173310

Locations: 🇺🇸
Indiana University Medical Center, Indianapolis, Indiana, United States
🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Stimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD

Not Applicable

Recruiting

Conditions: Parkinson Disease

Interventions: Device: Neuromodulation eXperiment Testbed system (NEXT) stimulation

First Posted Date: 2023-12-14

Last Posted Date: 2024-11-27

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 36

Registration Number: NCT06169852

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation

Phase 4

Recruiting

Conditions: Parathyroid Dysfunction
Adenoma

Interventions: Drug: Indocyanine green
Device: SPY Portable Handheld Imaging

First Posted Date: 2023-12-13

Last Posted Date: 2024-04-17

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 417

Registration Number: NCT06169735

Locations: 🇺🇸
UAB Callahan Eye, Birmingham, Alabama, United States

The Impact of Expressive Emotional Writing on Facilitating Grief Resolution in Adults With Spinal Cord Injury

Not Applicable

Recruiting

Conditions: Spinal Cord Injuries
Transverse Myelitis

Interventions: Behavioral: expressive writing

First Posted Date: 2023-11-27

Last Posted Date: 2024-05-06

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 60

Registration Number: NCT06147258

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Safety and Efficacy of Carbon Dioxide Gas for Endoscopy

Not Applicable

Recruiting

Conditions: Abdominal Pain

Interventions: Other: Endoscopic insufflation gas

First Posted Date: 2023-11-18

Last Posted Date: 2024-02-01

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 350

Registration Number: NCT06134154

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy